Ted Satterthwaite is McLure Associate Professor in Psychiatry and Behavioral Research at the University of Pennsylvania’s Perelman School of Medicine. He completed medical and graduate training at Washington University in St. Louis, where he was a student of Randy L. Buckner. Subsequently, he was a psychiatry resident and a neuropsychiatry fellow at Penn, under the mentorship of Raquel E. Gur. He joined the faculty of the psychiatry department in 2014 and served as director of imaging analytics at the Brain Behavior Laboratory from 2015 to 2019. Since 2020, he has directed the Penn Lifespan Informatics and Neuroimaging Center. His research uses multi-modal neuroimaging to describe both normal and abnormal patterns of brain development, in order to better understand the origins of neuropsychiatric illness. He has been the principal investigator on nine R01 grants from the National Institutes of Health. His work has been recognized with the Brain and Behavior Research Foundation’s Klerman Prize for Clinical Research, the NIMH Biobehavioral Research Award for Innovative New Scientists (BRAINS) award, the NIH Merit Award, as well as several teaching awards.
Ted Satterthwaite
McLure Associate Professor in Psychiatry and Behavioral Research
University of Pennsylvania
From this contributor
How scuba diving helped me embrace open science
Our lab adopted practices to make data- and code-sharing feel safer, including having the coding equivalent of a dive buddy. Trainees call the buddy system a welcome safety net.
How scuba diving helped me embrace open science
Explore more from The Transmitter
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.